OpenVSafe by OpenVAERS
Search V-safe

B2W-23407-50499

3 vaccinations 7 coded responses 25 check-ins 7 free-text entries 1 call case
Sex
Male
Age at first dose
61-65
ZIP prefix
537 / WI
Registered
2020-12-27
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-27
    Registered in v-safe
  2. 2020-12-27
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-27
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-28
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2020-12-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  6. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-03
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-10
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-01-17
    Dose 2 — Pfizer-BioNTech
  12. 2021-01-17
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-01-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Disturbance in attention, Dizziness, Neck pain — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Light headedness, decreased concentration, neck pain- soft tissue with full AROM
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-18
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  15. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-01-24
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-01-31
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-07
    Survey response — day 21, dose 2
    MedDRA: Headache, Oropharyngeal pain, SARS-CoV-2 antibody test negative — Feeling: Good · Be unable to work
    Free text: I developed a sore throat and mild headache on Thursday morning 2/4. Stayed home from work. Isolated. Tested negative for COVID. Back to clinic the next day.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-14
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-21
    Survey response — day 35, dose 2
    MedDRA: Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Good · Be unable to work
    Free text: Intermittent sore throat. Developed in the night on two occasions. No fever, marked congestion or other constitutional symptoms. Both resolved the day after. Took off one day of work to get tested. Result for COVID negative. Other was on weekend.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-02-28
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-18
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-11-19
    Dose 3 — Pfizer-BioNTech
  27. 2022-01-17
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2022-02-18
    Survey response — 3 months, dose 3
    MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Good
    Free text: Sore throat, rhinorrhea
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-05-20
    Survey response — 6 months, dose 3
    MedDRA: Oropharyngeal pain — Feeling: Good
    Free text: Sore throat x 2 days in mid April.
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-11-19
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Cough, Fatigue, Oropharyngeal pain — Feeling: Good · Be unable to work or attend school
    Free text: COVID with fatigue, sore throat, cough
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-27Pfizer-BioNTech
22021-01-17Pfizer-BioNTech
32021-11-19Pfizer-BioNTech No

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-28

Systemic reaction (other): No

Release 2 — days 1–6 daily, dose 2

2021-01-18

Systemic reaction (other): Light headedness, decreased concentration, neck pain- soft tissue with full AROM

Release 3 — day 21, dose 2

2021-02-07

Symptoms: I developed a sore throat and mild headache on Thursday morning 2/4. Stayed home from work. Isolated. Tested negative for COVID. Back to clinic the next day.

Release 4 — day 35, dose 2

2021-02-21

Symptoms: Intermittent sore throat. Developed in the night on two occasions. No fever, marked congestion or other constitutional symptoms. Both resolved the day after. Took off one day of work to get tested. Result for COVID negative. Other was on weekend.

Release 11 — 3 months, dose 3

2022-02-18

Symptoms: Sore throat, rhinorrhea

Release 11 — 6 months, dose 3

2022-05-20

Symptoms: Sore throat x 2 days in mid April.

Release 12 — 12 months, dose 3

2022-11-19

Symptoms: COVID with fatigue, sore throat, cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDCOVID-19 · · ✓
SDFatigue · · ✓
SDHeadache ✓ ✓ ✓
SDOropharyngeal pain ✓ ✓ ✓
SDRespiratory tract congestion ✓ ✓ ✓
SDRhinorrhoea · · ✓
SDSARS-CoV-2 antibody test negative ✓ ✓ ✓
SDSARS-CoV-2 test negative ✓ ✓ ✓
SRODisturbance in attention ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SRONeck pain ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release